Browse studies
Find your next paid study
15 recruiting studies matching your filters
Phase 1
A Phase 1 Study of TJ033721 in Subjects With Advanced or Metastatic Solid Tumors
This is an open label, multi-center, multiple dose Phase 1 study to evaluate the safety, tolerability, MTD PK, and PD of TJ033721 (givastomig) in subjects with…
Solid TumorAdvanced CancerMetastatic Cancer+5 more
Estimated
~$10 – $8,750
I-Mab Biopharma US LimitedNCT04900818
Phase 1
A Phase I/IIa Randomized Clinical Trial to Evaluate the Efficacy of EGFR-targeted, PNU-159682-packaged Nanocells & Glycolipid-Packaged Nanocells in Combination With Gemcitabine & Nab-paclitaxel in Metastatic Pancreatic Ductal Adenocarcinoma
The purpose of this study is to evaluate the safety and tolerability and overall survival (OS) of E-EDV-D682/GC in combination with gemcitabine and nab-paclita…
Pancreatic Cancer, MetastaticPDAC - Pancreatic Ductal Adenocarcinoma
Estimated
~$10 – $8,750
Engeneic Pty LimitedNCT07049055
A Prospective Registry for Patients at High-Risk for Pancreatic Cancer
This study aims to facilitate discovery and validation of tests for early detection in subjects at high risk for pancreatic ductal adenocarcinoma (PDAC) and to…
Pancreatic CancerPancreatic Ductal AdenocarcinomaPDAC+1 more
Estimated
~$10 – $750
Mayo ClinicNCT06151223